Definium Therapeutics

Develops psychedelic-based pharmaceutical treatments for psychiatric disorders.

BiotechnologyPharmaceuticals definiumtx.com ↗

Company facts

Founded
2019
Employees
106
Headquarters
United States
Type
Public
Listed
Nasdaq: DFTX
Subsidiaries
MindMed Discover, MindMed Pty Ltd.